Sirtuins as therapeutic targets of ALS. - Wikidata - awgldk - TriplyDB

Sirtuins as therapeutic targets of ALS.

Sirtuins as therapeutic targets of ALS.

http://www.wikidata.org/entity/Q34357662

about

Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways.SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells.A plural role for lipids in motor neuron diseases: energy, signaling and structure.Could Sirtuin Activities Modify ALS Onset and Progression?Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders Association of SIRT-1 Gene Polymorphism and Vitamin D Level in Egyptian Patients With Rheumatoid Arthritis.

P2860

Q28068499-B68383A9-C1B5-4424-9EBC-D6D788B0B135 Q36179578-89F534ED-E8EE-4BC9-A5A3-FEA5E945BCFD Q37029449-78A2FA30-380B-4CCC-883B-9775C1E55688 Q37594297-D598B073-52BC-4722-A181-CC1016120AE1 Q39036105-3CD6193F-E4A0-4BC0-A56C-196B080C0041 Q39101800-57664DDE-901D-4A01-8B93-A5C9C7863E59 Q41475139-C80FB0F8-B136-47C3-88E2-8EB63D2D8872 Q49871081-FF98D00F-EF68-41E5-9A7A-378A0A7F71EC

P2860

Sirtuins as therapeutic targets of ALS.

http://www.wikidata.org/entity/Q34357662

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Sirtuins as therapeutic targets of ALS.

@ast

Sirtuins as therapeutic targets of ALS.

@en

Sirtuins as therapeutic targets of ALS.

@nl

type

label

Sirtuins as therapeutic targets of ALS.

@ast

Sirtuins as therapeutic targets of ALS.

@en

Sirtuins as therapeutic targets of ALS.

@nl

prefLabel

Sirtuins as therapeutic targets of ALS.

@ast

Sirtuins as therapeutic targets of ALS.

@en

Sirtuins as therapeutic targets of ALS.

@nl

P1433

Q34357662-068CB108-19E4-4E9A-AA69-6716FA7DFEEB

P1476

Q34357662-48EC7BF1-68FE-434E-80EE-72ECFF74DFA3

P2093

Q34357662-23B63F6A-B5EB-4D0B-BBE3-05130E6BE127

Q34357662-87E70F6F-87DC-4286-86E2-2BE999A56A0A

Q34357662-9C4A9997-057D-468C-B161-0F3EC28E4180

P2860

Q34357662-283747C0-4A22-4A76-AD41-5C142FE6FBBE

Q34357662-6473DC0A-8E29-4346-80B2-9142D286D126

Q34357662-6F7B7700-097B-4D77-BEEB-E2E21547DC0F

Q34357662-8151C7E2-A1C9-4166-BAD9-581A149370A7

Q34357662-86559E5F-506C-4890-AC43-9E0BA90791B5

Q34357662-890F7F7D-62D2-4E81-A854-E2CFC7968907

Q34357662-9195C30A-2A46-40F3-9DCF-48B70C7F06A1

Q34357662-A0F526FA-8E3C-49D2-A262-FB2DA6F216F8

Q34357662-CE08EBF6-92CB-44B7-91B8-5E0909750D0A

Q34357662-F628A93C-4E38-4CC1-AB23-BA4B5B179E3E

P2888

Q34357662-E0BC3C4B-84A3-484D-B2AD-DBDA40AD51D2

P304

Q34357662-FF58EA1B-5D7E-4996-AD46-80B2393466CC

P31

Q34357662-7CB1B95A-5319-4FE6-BC04-58A619AE74F1

P356

Q34357662-B800F0AC-B130-4662-B50D-8DE4D9772353

P433

Q34357662-D7ED1EC8-F82B-426B-ACE6-51F222AFADDB

P478

Q34357662-E5B9F27D-FA72-4ADB-9F59-49460A5CED96

P577

Q34357662-BE1E27A3-41FA-4480-A056-EF68FC67AED8

P6179

Q34357662-27A3BF45-E017-449C-ABB2-6B78ED6ECB12

P698

Q34357662-CBE88788-378B-441C-ADB8-E614EAC9CCC0

P921

Q34357662-AB956282-2CB2-45B0-AD9A-8A3E6CAECD98

P932

Q34357662-D115EDF6-1D4D-4896-B863-93CE190B3EE9

P356

P1433

P1476

Sirtuins as therapeutic targets of ALS.

@en

P2093

Amanda E Bilski

http://www.w3.org/2001/XMLSchema#string

Giulio Maria Pasinetti

http://www.w3.org/2001/XMLSchema#string

Wei Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production

Mitochondria in sporadic amyotrophic lateral sclerosis.

Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes.

Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease

Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction.

Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis

Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α.

Peroxisome proliferator-activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype.

Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS?

Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice.

P2888

P304

1073-1074

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CR.2013.94

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034998705

http://www.w3.org/2001/XMLSchema#string

P698

23856645

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

3760621

http://www.w3.org/2001/XMLSchema#string